Clinuvel Pharmaceuticals Limited announced earnings results for the full year ended June 30, 2021. For the full year, the company announced total revenue was AUD 47.975 million compared to AUD 32.565 million a year ago. Net income was AUD 24.728 million compared to AUD 15.051 million a year ago. Basic earnings per share from continuing operations was AUD 0.5 compared to AUD 0.306 a year ago. Diluted earnings per share from continuing operations was AUD 0.484 compared to AUD 0.298 a year ago.